Rankings
▼
Calendar
CRON Q2 2020 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$981M
Q2 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$13M
Gross Profit
-$4M
-29.6% margin
Operating Income
-$101M
-755.9% margin
Net Income
-$145M
-1082.4% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+59.1%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$48M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$336M
Stockholders' Equity
$2.3B
Cash & Equivalents
$1.5B
Revenue Segments
Cannabis Flower
$6M
57%
Cannabis Extracts
$4M
41%
Product and Service, Other
$118,000
1%
Geographic Segments
CANADA
$7M
75%
UNITED STATES
$2M
22%
Other Countries
$293,000
3%
← FY 2020
All Quarters
Q3 2020 →